Navigation Links
Schering-Plough Shareholders Approve Merger With Merck
Date:8/7/2009

elating to marketed products or pipeline projects; media and societal reaction to such developments; and the ability of Schering-Plough and Merck to obtain governmental approvals of the merger on the proposed terms and schedule. For further details of these and other risks and uncertainties that may impact forward-looking statements, see Schering-Plough's Securities and Exchange Commission filings, including Part II, Item 1A "Risk Factors" in the company's second quarter 2009 10-Q, filed July 24, 2009 and "Risk Factors" in the joint merger proxy/prospectus dated June 25, 2009.

Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription, animal health and consumer health care products. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com.


'/>"/>
SOURCE Schering-Plough Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
2. Schering-Plough Announces Pricing of Senior Notes Offering
3. Schering-Plough to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
4. Schering-Plough Receives Approval from European Commission for Planned Acquisition of Organon BioSciences N.V.
5. Schering-Plough Completes Acquisition of Organon BioSciences
6. Schering-Plough Wins Three of Scrips Top Pharma Industry Awards
7. Schering-Plough Schedules Conference Call and Webcast for 2007 Fourth Quarter, Full-Year Financial Result
8. Schering-Plough to Webcast Presentation at Morgan Stanley Pharmaceutical CEOs Unplugged Conference
9. Schering-Plough Announces New Drug Application for Sugammadex Assigned Priority Review Status by U.S. FDA
10. Schering-Plough Announces Sugammadex New Drug Application Filed in Japan
11. FDA Grants Priority Review for Schering-Ploughs Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... 14 Array BioPharma Inc. (Nasdaq: ... today announced that they entered into an agreement ... glucokinase activator program, including ARRY-403, currently being tested ... with Type 2 diabetes. ,, Under ... an upfront payment of $60 million and additional ...
(Date:12/14/2009)... Dec. 14 Boston Scientific Corporation (NYSE: ... public offering of $2 billion aggregate principal amount of ... The public offering consists of $850 million of ... 6.00 percent notes due January 2020 and $300 million ... Scientific plans to use the net proceeds for general ...
(Date:12/14/2009)... BRUSSELS, December 14 , ... Lifestyles of,Women With Rheumatoid Arthritis in Seven Major Industrialized Countries ... living with rheumatoid arthritis say their disease, ... - Women living with rheumatoid arthritis find shopping ... writing cards and wrapping presents most, ...
(Date:12/11/2009)... have observed the "hot electron" effect in a solar ... elusive charges using ultra-thin solar cells, opening a potential ... in the current online edition of Applied Physics ... cells, it generates free electrons in a range of ... the electrons must reach the bottom of the conduction ...
Breaking Biology Technology:Array BioPharma and Amgen Partner in Type 2 Diabetes 2Array BioPharma and Amgen Partner in Type 2 Diabetes 3Array BioPharma and Amgen Partner in Type 2 Diabetes 4Array BioPharma and Amgen Partner in Type 2 Diabetes 5Array BioPharma and Amgen Partner in Type 2 Diabetes 6Array BioPharma and Amgen Partner in Type 2 Diabetes 7Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 2Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 3Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 2Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 3Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 4Elusive 'hot' electrons captured in ultra-thin solar cells 2
... himself from other presidential wannabes, former Wisconsin governor and ... candidate of new ideas in the 2008 presidential race, ... of electronic health records following his keynote address at ... Medical Device Association . , ,The conference, held at ...
... Milwaukee, Wis. - Two southeastern Wisconsin medical ... personal health records. , ,The agreement between TeraMedica ... Inc . of Germantown will merge technology products with ... to images and other patient information. , ,TeraMedica, a ...
... - A University of Wisconsin-Madison master's degree ... the nation, according to BusinessWeek 's latest " Best ... 2006 paid $186,800 for their MBAs and started earning salaries ... four and a half years, not counting lost income for ...
Other Biology Technology:Tommy Thompson says capital needed for electronic health records 2Tommy Thompson says capital needed for electronic health records 3Tommy Thompson says capital needed for electronic health records 4UW-Madison MBA program ranked among best for investment return 2
(Date:12/13/2009)... how a popular class of drugs used to ... hidden components of chemical communication in the brain. ... illness, people with schizophrenia also struggle to sustain ... difficulties that interfere with their ability to hold ... a student in the medical scientist training program ...
(Date:12/13/2009)... The Scripps Research Institute have solved a 10-year-old ... ancient family of enzymes can have two completely ... providing guidance for understanding other molecules in the ... the protein,s possible use for combating diseases including ... published in the December 13, 2009 advance, online ...
(Date:12/11/2009)... Malus orientalis species of wild apples that could be ... Middle East and Central Asia. A new study comparing ... varieties from Georgia and Armenia with previously collected varieties ... and establishes a core collection that will make ... research communities. , To identify and record the genetic ...
Breaking Biology News(10 mins):New biosensors reveal workings of anti-psychotic drugs in the living brain 2Scripps Research scientists crack mystery of protein's dual function 2Scripps Research scientists crack mystery of protein's dual function 3Understanding apples' ancestors 2Babies language learning starts from the womb 60760 1Babies language learning starts from the womb 60760 2Green Tea May Help Prevent Oral Cancer 60757 1Green Tea May Help Prevent Oral Cancer 60757 2SXC Health solutions announces record third quarter financial results 60754 1SXC Health solutions announces record third quarter financial results 60754 2SXC Health solutions announces record third quarter financial results 60754 3SXC Health solutions announces record third quarter financial results 60754 4SXC Health solutions announces record third quarter financial results 60754 5SXC Health solutions announces record third quarter financial results 60754 6SXC Health solutions announces record third quarter financial results 60754 7SXC Health solutions announces record third quarter financial results 60754 8SXC Health solutions announces record third quarter financial results 60754 9SXC Health solutions announces record third quarter financial results 60754 10SXC Health solutions announces record third quarter financial results 60754 11SXC Health solutions announces record third quarter financial results 60754 12SXC Health solutions announces record third quarter financial results 60754 13SXC Health solutions announces record third quarter financial results 60754 14SXC Health solutions announces record third quarter financial results 60754 15SXC Health solutions announces record third quarter financial results 60754 16SXC Health solutions announces record third quarter financial results 60754 17SXC Health solutions announces record third quarter financial results 60754 18SXC Health solutions announces record third quarter financial results 60754 19SXC Health solutions announces record third quarter financial results 60754 20
... at the University of California, Berkeley, have identified a new ... in controlling the breakdown of fat. In a new study ... Medicine , researchers report that mice that have had this ... losing a hormone that suppresses appetite. , "We have discovered ...
... Scripps Research Institute scientists has taken a significant step toward ... time RNA enzymes that can replicate themselves without the help ... proceeds indefinitely. , The work was published on Thursday, ... online edition of the journal Science . , In ...
... communication once graduates enter the workforce, Stevens Institute of ... oral and written skills of undergraduate students. , ... the Writing and Communications at the Institute (WCI) program ... engineering students in their junior and senior years, said ...
Other Biology News:Disabling enzyme allows mice to gorge without becoming obese, new study finds 2Disabling enzyme allows mice to gorge without becoming obese, new study finds 3Scripps scientists develop first examples of RNA that replicates itself indefinitely 2Scripps scientists develop first examples of RNA that replicates itself indefinitely 3Scripps scientists develop first examples of RNA that replicates itself indefinitely 4Stevens receives $25,000 grant from the Engineering Information Foundation 2
... G|2 Doublestain System is a high-sensitivity ... kit. The kit is intended for ... detection of two different antigens within ... with suitably diluted rabbit and mouse ...
Anti-TNKS2 Polyclonal AntibodyOther Sub-Family: not assigned-Other Applications: ELISA, Western Blot...
... (Vesicle-Associated Membrane Protein 2, Synaptobrevin ... share homology with any other ... is expected that the antibody ... Macaca multata and bovine due ...
... encodes two unrelated proteins both of which ... cell cycle in a p53-dependent manner. p14^ARF^ ... degradation of mdm2 proteinrequired for mdm2 modification ... This interaction is mediated by the exon ...
Biology Products: